Press release
Uveitis Treatment Market to Reach USD 855 Million by 2034
Uveitis Treatment Market
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49855
Key Takeaways
• Market Size (2024): USD 545 Million
• Forecast (2034): USD 855 Million
• CAGR (2025-2034): 4.6%
• Major Drivers: Growing cases of infectious and non-infectious uveitis, advances in corticosteroid implants, and rising awareness of early diagnosis.
• Leading Players: AbbVie Inc., Novartis AG, Bausch Health Companies Inc., EyePoint Pharmaceuticals, Santen Pharmaceutical Co. Ltd., Allergan plc, Regeneron Pharmaceuticals Inc., and Alimera Sciences Inc.
Market Story
Uveitis, an inflammation of the uveal tract in the eye, remains a major cause of vision loss globally. Its management has evolved significantly with the introduction of biologic therapies, sustained-release corticosteroid implants, and advanced immunosuppressive agents.
Traditional treatments relied heavily on corticosteroids and systemic immunomodulators; however, the modern landscape is shifting toward precision medicine, where biologics such as adalimumab (Humira) and infliximab target specific inflammatory pathways.
Further, innovations in intraocular drug delivery, biodegradable implants, and AI-based imaging tools are enhancing early diagnosis, treatment adherence, and long-term disease monitoring. The availability of tele-ophthalmology platforms has also improved patient access to specialized care, particularly in developing regions.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/49855/uveitis-treatment-market
Market Segmentation
By Drug Class:
• Corticosteroids
• Immunosuppressants
• Biologics
• Cycloplegic Agents
• Antiviral/Antibacterial Drugs
By Disease Type:
• Anterior Uveitis
• Intermediate Uveitis
• Posterior Uveitis
• Panuveitis
By Route of Administration:
• Oral
• Topical
• Injectable
• Implant
By End-User:
• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers
• Research Institutes
By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
Recent Developments
• 2025: EyePoint Pharmaceuticals launched a next-gen sustained-release corticosteroid implant for chronic non-infectious posterior uveitis.
• 2024: AbbVie Inc. reported expanded indications for Humira® and its biosimilars in treating autoimmune eye inflammation.
• 2024: Santen Pharmaceutical announced a strategic collaboration to develop biologic eye drops targeting cytokine pathways.
• 2023: Novartis AG advanced its phase III clinical trials for a novel IL-17 inhibitor targeting refractory uveitis patients.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49855
Expert Insight
"The convergence of immunology and ophthalmology is redefining uveitis treatment," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
"With biologics, long-acting implants, and AI-assisted imaging, ophthalmologists are better equipped to manage chronic inflammation and preserve vision over the long term."
Regional Outlook
• North America dominates the market with over 40% share, driven by early biologic adoption, established healthcare infrastructure, and a strong clinical research pipeline.
• Europe follows with a focus on sustainable drug delivery systems and reimbursement support for rare ocular diseases.
• Asia Pacific is projected to grow at 6.1% CAGR, fueled by the growing patient base in India and China, improved diagnosis rates, and expansion of ophthalmic specialty centers.
• Latin America & Middle East regions are witnessing increasing clinical collaborations and improved access to immunomodulatory therapies.
Conclusion
The Uveitis Treatment Market is transitioning toward precision-based, long-term therapeutic strategies supported by biologics and implantable delivery systems. As innovation in ophthalmic biotechnology and diagnostic imaging accelerates, the next decade will see improved disease control, reduced recurrence rates, and enhanced patient quality of life globally.
This report is also available in the following languages : Japanese (ぶどう膜炎治療市場), Korean (포도막염 치료 시장), Chinese (葡萄膜炎治疗市场), French (Marché des traitements contre l'uvéite), German (Markt für Uveitis-Behandlungen), and Italian (Mercato del trattamento dell'uveite), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49855
Our More Reports:
Hemiplegic Migraine Market
https://exactitudeconsultancy.com/reports/49160/hemiplegic-migraine-market
Integrated Operating Room Management Systems Market
https://exactitudeconsultancy.com/reports/49163/integrated-operating-room-management-systems-market
Corporate Wellness Market
https://exactitudeconsultancy.com/reports/49166/corporate-wellness-market
Biochips Market
https://exactitudeconsultancy.com/reports/49169/biochips-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uveitis Treatment Market to Reach USD 855 Million by 2034 here
News-ID: 4266646 • Views: …
More Releases from Exactitude Consultancy
Airway Management Market to Reach USD 2.45 Billion by 2034
Pune, India, November 2025 - A new report from Exactitude Consultancy reveals that the Global Airway Management Market is valued at USD 1.58 billion in 2024 and is projected to reach USD 2.45 billion by 2034, expanding at a CAGR of 4.5% during 2025-2034. The market is witnessing robust growth driven by increasing surgical procedures, rising prevalence of chronic respiratory diseases, and the widespread adoption of advanced airway management technologies…
Intrauterine Contraceptive Devices Market to Reach USD 6.7 Billion by 2034
Pune, India, November 11, 2025 - The global Intrauterine Contraceptive Devices (IUD) Market is expected to rise from USD 4.3 billion in 2024 to USD 6.7 billion by 2034, registering a CAGR of 4.5 %, according to Exactitude Consultancy. Growing awareness of long-acting reversible contraception (LARC), rising government investment in family-planning programs, and product innovation in hormonal and non-hormonal IUDs are propelling market growth worldwide.
Download Full PDF Sample Copy of…
Oral Cancer Diagnostics Market to Reach USD 3.7 Billion by 2034
Pune, India, November 2025 - According to the latest report by Exactitude Consultancy, the Global Oral Cancer Diagnostics Market is valued at USD 2.2 billion in 2024 and is projected to reach USD 3.7 billion by 2034, growing at a CAGR of 5.2% during 2025-2034. Market growth is driven by rising tobacco and alcohol consumption, increasing awareness about oral cancer screening, and significant technological advancements in early-stage diagnostic tools.
Download Full…
Vitiligo Treatment Market to Reach USD 2.1 Billion by 2034
Pune, India, November 11, 2025 - The global Vitiligo Treatment Market is projected to grow from USD 1.3 billion in 2024 to USD 2.1 billion by 2034, registering a CAGR of 5.0 %, according to Exactitude Consultancy. Growing awareness of autoimmune skin disorders, rapid approval of JAK-inhibitor-based therapies, and increasing investment in dermatology R&D are transforming the treatment landscape for vitiligo worldwide.
Download Full PDF Sample Copy of Market Report @…
More Releases for Uveitis
Uveitis Market : An Overview Report
Introduction:
Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis…
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of…
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based…
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview
Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures.
Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html
As per Cochrane,…
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &…
